X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC LTD Fact Sheet, ALEMBIC LTD Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD Fact Sheet   (ALMC)

Here is the latest financial fact sheet of ALEMBIC LTD. For more details, see the ALEMBIC LTD quarterly results and ALEMBIC LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC LTD Price History

Price Rs 67.6
Mkt Cap Rs m 37,437
Vol '000 1,431.5
P/E X 136.1
P/CF X 121.5
EPS (TTM) Rs 0.5
% ch % 6.7
No. of shares m 553.80
% ch week % 13.1
% ch 1-mth % 21.6
% ch 12-mth % 85.5
52 week H/L Rs 69.5/33.9
(As on Jan 22, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC LTD Financials

No. of Mths
Year Ending
12
Mar-12
12
Mar-13
12
Mar-14
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
ALEMBIC LTD EQUITY SHARE DATA
High Rs4020187053 
Low Rs141471629 
Sales per share (Unadj.) Rs9.013.45.85.44.7 
Earnings per share (Unadj.) Rs-0.90.91.14.08.8 
Diluted earnings per shareRs-0.20.20.51.94.2 
Cash flow per share (Unadj.) Rs-0.11.61.24.29.0 
Dividends per share (Unadj.) Rs00.200.150.150.15 
Adj. dividends per shareRs0.000.050.070.070.07 
Dividend yield (eoy) %01.21.20.30.4 
Book value per share (Unadj.) Rs14.815.48.619.827.7 
Adj. book value per shareRs3.63.74.29.513.4 
Shares outstanding (eoy) m133.52133.52267.03267.03267.03 
Bonus/Rights/Conversions  --B1:1-- 
Price / Sales ratio x3.01.32.18.08.7 
Avg P/E ratio x-29.519.811.210.84.7 
P/CF ratio (eoy) x-283.910.610.410.24.6 
Price / Book Value ratio x1.81.11.42.21.5 
Dividend payout %023.213.63.81.7 
Avg Mkt Cap Rs m3,6052,2703,29811,46910,962 
No. of employees `000NANANANANA 
Total wages/salary Rs m255245273270238 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC LTD INCOME DATA
Net Sales Rs m1,2081,7921,5361,4391,260 
Other income Rs m65103158208264 
Total revenues Rs m1,2721,8951,6941,6471,524 
Gross profit Rs m-151572239583 
Depreciation Rs m10998236061 
Interest Rs m52512380 
Profit before tax Rs m-111110335235285 
Minority Interest Rs m00000 
Prior Period Items Rs m0008252,096 
Extraordinary Inc (Exp) Rs m-25000-32 
Tax Rs m-14-539-76 
Profit after tax Rs m-1221152951,0662,343 
Gross profit margin %-1.28.714.56.66.6 
Effective tax rate %12.7-4.411.8-2.92.1 
Net profit margin %-10.16.419.274.1185.9 
ALEMBIC LTD BALANCE SHEET DATA
Current assets Rs m1,7001,2901,5431,6091,689 
Current liabilities Rs m1,6311,070907533486 
Net working cap to sales %5.712.341.474.895.4 
Current ratio x1.01.21.73.03.5 
Inventory Days Days285198248214217 
Debtors Days Days48376612281 
Net fixed assets Rs m1,9541,8841,8001,7151,624 
Share capital Rs m267267534534534 
"Free" reserves Rs m4988928743,8395,960 
Net worth Rs m1,9722,0582,3075,2787,404 
Long term debt Rs m0302331354104 
Total assets Rs m3,9153,4403,5626,1928,010 
Interest coverage x-1.13.115.429.3950.7 
Debt to equity ratio x00.10.10.10 
Sales to assets ratio x0.30.50.40.20.2 
Return on assets %-1.84.88.917.429.3 
Return on equity %-6.25.612.820.231.6 
Return on capital %-4.36.813.619.031.3 
Exports to sales %7.14.47.714.32.9 
Imports to sales %5.40.93.42.528.9 
Exports (fob) Rs m867911820537 
Imports (cif) Rs m66175237364 
Fx inflow Rs m867911820537 
Fx outflow Rs m70386342365 
Net fx Rs m164155163-328 
ALEMBIC LTD CASH FLOW
From Operations Rs m -591 803 -102 220 346 
From Investments Rs m -54 121 178 47 -48 
From Financial Activity Rs m 646 -943 -79 -250 -301 
Net Cashflow Rs m 1 -19 -3 17 -3 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 64.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.2%
FIIs 9.7%
ADR/GDR 0.0%
Free float 26.1%
Shareholders 54,701
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, Vadodara - 390 003
E-MAIL alembic.investors@alembic.co.in WEB www.alembiclimited.com
TELEPHONE (0265) 228 0550 FAX (0265) 228 2506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, 1st Flr., Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Chirag K. Shukla YEAR OF INC: 1907 BSE CODE: 506235 FV (Rs): 2 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   IPCA LABS  GLENMARK PHARMA  CADILA HEALTHCARE  NOVARTIS  FULFORD INDIA  

Compare ALEMBIC LTD With:   IPCA LABS  GLENMARK PHARMA  CADILA HEALTHCARE  NOVARTIS  FULFORD INDIA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC LTD

ALEMBIC LTD - J.B.CHEMICALS COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS